Why we need to prioritize developing antibiotics for children
Author:
Manica Balasegaram
Tags:
Antimicrobial Viewpoint article,
Discovery,
Lead-to-candidate,
Phase 1,
Phase 2,
Phase 3,
Preclinical development,
Regulatory,
Bloodstream infection,
STI,
Acinetobacter baumannii,
Enterobacteriaceae,
Escherichia coli,
Klebsiella pneumoniae,
MDR,
WHO priority pathogens,
Access,
Stewardship
